No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism

Molecular Brain Research

Volumn 59, Issue 1, 1998, Pages 13-21

  Hatanpää, Kimmo ^a,b   Chandrasekaran, Krish ^b   Brady, Daniel R ^b   Rapoport, Stanley I ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Amyloid beta protein; Cytochrome oxidase; Immunohistochemistry; In situ hybridization; Mitochondria; Polyadenylated mRNA

Indexed keywords

AMYLOID BETA PROTEIN; CYTOCHROME C OXIDASE; MESSENGER RNA; MITOCHONDRIAL DNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN NERVE CELL; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CELL COUNT; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOTOR CORTEX; NEURONS; RNA, MESSENGER; SENILE PLAQUES; TEMPORAL LOBE;

EID: 0032528999     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00117-X     Document Type: Article

References (62)

1. Abacus Concepts, SuperANOVA, Vol. Abacus Concepts, Berkeley, CA, 1989, 322 pp.
2. P. Arriaga, J. Growdon, E. Hedley-Whyte, B. Hyman, Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology 42 (1992) 631-639.
3. I. Borowsky, R. Collins, Histochemical changes in enzymes of energy metabolism in the dentate gyrus accompany deafferentation and synaptic reorganization, Neuroscience 33 (1989) 253-262.
4. I. Borowsky, R. Collins, Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities, J. Comp. Neurol. 288 (1989) 401-413.
5. S. Brining, C. Jones, M. Chang, Effects of chronic beta-amyloid treatment on fatty acid incorporation into rat brain, Neurobiol. Aging 17 (1996) 301-309.
6. J. Brion, A. Couck, M. Bruce, B. Anderton, J. Flament-Durant, Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease, Brain Res. 539 (1991) 143-150.
7. K. Chandrasekaran, T. Giordano, D. Brady, J. Stoll, L. Martin, S. Rapoport, Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease, Mol. Brain Res. 24 (1994) 336-340.
8. K. Chandrasekaran, K. Hatanpaa, D. Brady, S. Rapoport, Evidence for physiological downregulation of brain oxidative phosphorylation in Alzheimer's disease, Exp. Neurol. 142 (1996) 80-88.
9. P. Cras, M. Smith, P. Richey, S. Siedlak, P. Mulvihill, G. Perry, Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease, Acta Neuropathol. (Berlin) 89 (1995) 291-295.
10. C. DeCarli, J. Atack, M. Ball et al., Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients, Neurodegeneration 1 (1992) 113-121.
11. E. Deyoe, T. Trusk, M. Wong-Riley, Activity correlates of cytochrome oxidase-defined compartments in granular and supragranular layers of primary visual cortex of the macaque monkey, Vis. Neurosci. 12 (1995) 629-639.
12. J. Dodart, H. Meziane, C. Mathis, K. Bales, S. Paul, A. Ungerer, Memory and learning impairment precede amyloid deposition in the V717F PDAPP transgenic mouse, Soc. Neurosci. Abstr. 23 (1997) 1637.
13. M. Esiri, R. Pearson, J. Steele, D. Bowen, T. Powell, A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry 53 (1990) 161-165.
14. R. Friede, Enzyme histochemical studies of senile plaques, J. Neuropathol. Exp. Neurol. 24 (1965) 477-491.
15. R. Friede, K. Magee, Alzheimer's disease: presentation of a case with pathologic and enzymatic-histochemical observations, Neurology 12 (1962) 213-222.
16. M. Fujii, Y. Katayama, Y. Makiyama, S. Maejima, T. Tsubokawa, Dynamic changes in cytochrome oxidase activity in the rat somatosensory cortex following thalamocortical deafferentation, Neurol. Res. 15 (1993) 384-388.
17. R. Fukuyama, K. Wadhwani, Z. Galdzicki, S. Rapoport, G. Ehrenstein, Beta-amyloid polypeptide increases calcium uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease, Brain Res. 667 (1994) 269-272.
18. Z. Galdzicki, R. Fukuyama, K. Wadhwani, S. Rapoport, G. Ehrenstein, Beta-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease, Brain Res. 646 (1994) 332-336.
19. D. Games, K. Khan, F. Soriano, P. Keim, D. Davis, K. Bryant, I. Lieberburg, Lack of Alzheimer pathology after beta-amyloid protein injections in the rat brain, Neurobiol. Aging 13 (1992) 569-576.
20. L. Ginsberg, S. Rafique, J. Xuereb, S. Rapoport, N. Gershfeld, Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain, Brain Res. 698 (1995) 223-226.
21. T. Gomez-Isla, R. Hollister, H. West, S. Mui, J. Growdon, R. Petersen, J. Parisi, B. Hyman, Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann. Neurol. 41 (1997) 17-24.
22. S. Greenberg, P. Davies, J. Schein, L. Binder, Hydrofluoric acid-treated tau-PHF proteins display the same biochemical properties as normal tau, J. Biol. Chem. 267 (1992) 564-569.
23. R. Guntern, C. Bouras, P. Hof, P. Vallet, An improved thioflavin S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease, Experientia 48 (1992) 8-10.
24. J. Hardy, New insights into the genetics of Alzheimer's disease, Ann. Med. 28 (1996) 255-258.
25. Y. Harigaya, M. Shoji, T. Shirao, S. Hirai, Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease, J. Neurosci. Res. 43 (1996) 87-92.
26. K. Hatanpää, D. Brady, S. Rapoport, K. Chandrasekaran, Neuronal energy metabolism is not educed by senile plaques in Alzheimer's disease, Soc. Neurosci. Abstr. 23 (1996) 1174.
27. K. Hatanpää, D. Brady, J. Stoll, S. Rapoport, K. Chandrasekaran, Neuronal activity and early neurofibrillary tangles in Alzheimer's disease, Ann. Neurol. 40 (1996) 411-420.
28. R. Hevner, L. Suyan, M. Wong-Riley, An optimized method for determining cytochrome oxidase activity in brain tissue homogenates, J. Neurosci. Methods 50 (1993) 309-319.
29. R. Hevner, M. Wong-Riley, Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein, J. Neurosci. 11 (1991) 1942-1958.
30. R. Hevner, M. Wong-Riley, Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionally regulated by functional activity in neurons, J. Neurosci. 13 (1993) 1805-1819.
31. B. Hyman, M. Irizarry, F. Soriano, M. McNamara, K. Page, D. Schenk, D. Games, Ab deposition is associated with neuritic changes and gliosis, but not with overt neuronal loss in the PDAPP transgenic mouse, Soc. Neurosci. Abstr. 23 (1997) 1115.
32. L. Iversen, R. Mortishire-Smith, S. Pollack, M. Shearman, The toxicity in vitro of beta-amyloid protein, Biochem. J. 311 (1995) 1-16.
33. C. Kim, L. Pier, P. Spear, Effects of aging on numbers and sizes of neurons in histochemically defined subregions of monkey striate cortex, Anat. Rec. 247 (1997) 119-128.
34. S. Kish, C. Bergeron, A. Rajput, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem. 59 (1992) 776-779.
35. N. Kowall, M. Beal, J. Busciglio, L. Duffy, B. Yankner, An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7247-7251.
36. N. Kowall, A. McKee, B. Yankner, M. Beal, In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment, Neurobiol. Aging 13 (1991) 537-542.
37. Y. Kuo, M. Emmerling, V.-P. C, T. Kasunic, J. Kirkpatrick, G. Murdoch, M. Ball, A. Roher, Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem. 271 (1996) 4077-4081.
38. A. Lorenzo, B. Yankner, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12243-12247.
39. E. Masliah, M. Ellisman, B. Carragher, M. Mallory, S. Young, L. Hansen, R. DeTeresa, R. Terry, Three dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease, J. Neuropathol. Exp. Neurol. 51 (1992) 404-414.
40. M. Mattson, Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise, Ann. New York Acad. Sci. 747 (1994) 50-76.
41. M. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, R. Rydel, Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci. 12 (1992) 376-398.
42. S. Mirra, M. Hart, R. Terry, Making the diagnosis of Alzheimer's disease, Arch. Pathol. Lab. Med. 117 (1993) 132-144.
43. E. Mutisya, A. Bowling, M. Beal, Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J. Neurochem. 63 (1994) 2179-2184.
44. R. Neve, Mixed signals in Alzheimer's disease, TINS 19 (1996) 371-372.
45. R. Nitsch, J. Growdon, Role of neurotransmission in the regulation of amyloid beta-protein precursor processing, Biochem. Pharmacol. 47 (1994) 1275-1284.
46. L. Otvos, L. Feiner, E. Lang, Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404, J. Neurosci. Res. 39 (1994) 669-673.
47. C. Pike, A. Walencewicz, C. Glabe, C. Cotman, In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res. 563 (1991) 311-314.
48. M. Podlisny, D. Stephenson, M. Frosch, I. Lieberburg, J. Clemens, D. Selkoe, Synthetic amyloid beta-protein fails to produce specific neurotoxicity in monkey cerebral cortex, Neurobiol. Aging 13 (1992) 561-567.
49. D. Praprotnik, M. Smith, P. Richey, H. Vinters, G. Perry, Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress, Acta Neuropathol. 91 (1996) 1-5.
50. S. Rapoport, Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review, Cerebrovasc. Brain Metab. Rev. 3 (1991) 297-335.
51. S. Rapoport, K. Hatanpaa, D. Brady, K. Chandrasekaran, Brain energy metabolism, cognitive function and downregulated oxidative phosphorylation in Alzheimer disease, Neurodegeration 5 (1996) 473-476.
52. M. Schmidt, A. DiDario, V. Lee, J. Trojanowski, An extensive network of PHFtau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease, FEBS Lett. 344 (1994) 69-73.
53. N. Simonian, B. Hyman, Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation, J. Neuropathol. Exp. Neurol. 52 (1994) 580-585.
54. N. Simonian, B. Hyman, Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation, J. Neuropathol. Exp. Neurol. 53 (1994) 508-512.
55. M. Tabaton, M. Nunzi, R. Xue, M. Usiak, L. Autilio-Gambetti, P. Gambetti, Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid, Biochem. Biophys. Res. Commun. 200 (1994) 1598-1603.
56. R. Terry, A. Peck, R. DeTeresa, R. Schechter, D. Horoupian, Some morphometric aspect of the brain in senile dementia of the Alzheimer type, Ann. Neurol. 10 (1981) 184-192.
57. S. Vasan, X. Zhang, X. Zhang, A. Kapurniotu, J. Bernhagen, S. Teichberg, J. Basgen, D. Wagle, D. Shih, I. Terlecky, R. Bucala, A. Cerami, J. Egan, P. Ulrich, An agent cleaving glucose-derived protein crosslinks in vitro and in vivo, Nature 382 (1996) 275-278.
58. D. Wharton, A. Tzagoloff, Cytochrome oxidase from beef mitochondria, Methods Enzymol. 10 (1967) 245-250.
59. M. Wong-Riley, Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry, Brain Res. 171 (1979) 11-28.
60. M. Wong-Riley, Cytochrome oxidase: an endogenous metabolic marker for neuronal activity, Trends Neurosci. 12 (1989) 94-101.
61. M. Wong-Riley, S. Walsh, P. Leake-Jones, M. Merzenich, Maintenance of neuronal activity by electrical stimulation of unilaterally deafened cats demonstrable with cytochrome oxidase technique, Ann. Otol. Rhinol. Laryngol. Suppl. 90 (1981) 30-32.
62. S. Wood, L. MacKenzie, B. Maleeff, M. Hurle, R. Wetzel, Selective inhibition of Abeta fibril formation, J. Biol. Chem. 271 (1996) 4086-4092.